Latest Organofluorides Stories
The Firm is representing numerous Risperdal lawsuit plaintiffs who allegedly developed gynecomastia (male breast growth) due to their use of the medication. New
The United States is the biggest market for micronized PTFE, followed by China, and is projected to grow at a CAGR of 7.08% between 2014 and 2019.
-- Results of Investigational Studies of Perampanel and Rufinamide Accepted as Late-Breaking Posters -- WOODCLIFF LAKE, N.J., Dec. 5, 2014 /PRNewswire/ -- Eisai Inc.
The Firm is representing numerous clients who have filed Risperdal lawsuits after allegedly developing gynecomastia, or male breast growth, due to the antipsychotic medication. New
LONDON and PITTSBURGH, Dec. 4, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S.
PITTSBURGH and LONDON, Dec. 4, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S.
The Firm is currently representing men and young boys in Risperdal lawsuits that allege male gynecomastia due to their use of the antipsychotic medication. New
Novel Emerging Therapies Are Expected to Reinvigorate a Market Constrained By Patent Expirations of Leading Treatments, According to Findings from Decision Resources Group BURLINGTON, Mass.,
- Update on complete remissions with personalized cell therapy CTL019 in patients with relapsed/refractory acute lymphoblastic leukemia EAST HANOVER, N.J., Dec.
FOR U.S. MEDIA ONLY WOODCLIFF LAKE, N.J., Dec.
- A poem in which the author retracts something said in an earlier poem.